HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

P-glycoprotein restricts the penetration of oseltamivir across the blood-brain barrier.

Abstract
Oseltamivir is an ethyl ester prodrug of [3R,4R,5S]-4-acetamido-5-amino-3-(1-ethylpropoxy)-1-cyclohexene-1-carboxylate phosphate (Ro 64-0802), the anti-influenza drug. Abnormal behavior has been suspected to be associated with oseltamivir medication in Japan. The purpose of the present study is to examine the involvement of transporters in the brain distribution of oseltamivir and its active form Ro 64-0802 across the blood-brain barrier (BBB). The brain-to-plasma concentration ratio (K(p,brain)) of oseltamivir after i.v. infusion of oseltamivir in FVB mice was increased by pretreatment with N-(4-[2-(1,2,3,4-tetrahydro-6,7-dimethoxy-2-isoquinolinyl)ethyl]-phenyl)-9,10-dihydro-5-methoxy-9-oxo-4-acridine carboxamide (GF120918), a dual inhibitor for P-glycoprotein (P-gp) and breast cancer resistance protein (Bcrp), whereas that of Ro 64-0802 was only slightly increased. Furthermore, the distribution volume of Ro 64-0802 following i.v. administration of Ro 64-0802 in the brain was similar to the capillary volume, suggesting its minimal distribution. The K(p,brain) value of oseltamivir in multidrug-resistant (Mdr) 1a/1b P-gp knockout mice was 5.5-fold higher than that in wild-type mice and comparable with that obtained by pretreatment with GF120918, whereas it was unchanged in Bcrp knockout mice. The K(p,brain) value of oseltamivir was significantly higher in newborn rats, which is in good agreement with the ontogenetic expression profile of P-gp. Intracellular accumulation of oseltamivir was lower in human and mouse P-gp-expressing cells, which was reversed by P-gp inhibitor valspodar (PSC833). These results suggest that P-gp limits the brain uptake of oseltamivir at the BBB and that Ro 64-0802 itself barely crosses the BBB. However, it may be possible that Ro 64-0802 is formed in the brain from the oseltamivir, considering the presence of carboxylesterase in the brain endothelial cells.
AuthorsAtsushi Ose, Hiroyuki Kusuhara, Kenzo Yamatsugu, Motomu Kanai, Masakatsu Shibasaki, Takuya Fujita, Akira Yamamoto, Yuichi Sugiyama
JournalDrug metabolism and disposition: the biological fate of chemicals (Drug Metab Dispos) Vol. 36 Issue 2 Pg. 427-34 (Feb 2008) ISSN: 1521-009X [Electronic] United States
PMID18039806 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • ATP Binding Cassette Transporter, Subfamily B
  • ATP Binding Cassette Transporter, Subfamily G, Member 2
  • ATP-Binding Cassette Transporters
  • Abcg2 protein, mouse
  • Acetamides
  • Acridines
  • Antiviral Agents
  • P-glycoprotein 2
  • Prodrugs
  • RNA, Messenger
  • Ro 64-0802
  • Tetrahydroisoquinolines
  • Oseltamivir
  • multidrug resistance protein 3
  • Elacridar
Topics
  • ATP Binding Cassette Transporter, Subfamily B (antagonists & inhibitors, genetics, metabolism)
  • ATP Binding Cassette Transporter, Subfamily G, Member 2
  • ATP-Binding Cassette Transporters (antagonists & inhibitors, genetics, metabolism)
  • Acetamides (blood, pharmacokinetics, pharmacology)
  • Acridines (pharmacology)
  • Animals
  • Antiviral Agents (blood, pharmacokinetics, pharmacology)
  • Blood-Brain Barrier (metabolism)
  • Brain (drug effects, metabolism)
  • Cell Line
  • Dogs
  • LLC-PK1 Cells
  • Male
  • Mice
  • Mice, Knockout
  • Oseltamivir (blood, pharmacokinetics, pharmacology)
  • Prodrugs (pharmacokinetics, pharmacology)
  • RNA, Messenger (metabolism)
  • Rats
  • Rats, Wistar
  • Swine
  • Tetrahydroisoquinolines (pharmacology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: